Page last updated: 2024-10-25

cimetidine and Lupus Erythematosus, Cutaneous, Subacute

cimetidine has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marzano, AV1
Capsoni, F1
Berti, E1
Gasparini, G1
Bottelli, S1
Caputo, R1

Other Studies

1 other study available for cimetidine and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
Amicrobial pustular dermatosis of cutaneous folds associated with autoimmune disorders: a new entity?
    Dermatology (Basel, Switzerland), 1996, Volume: 193, Issue:2

    Topics: Adult; Ascorbic Acid; Autoantibodies; Autoimmune Diseases; Celiac Disease; Chemotaxis, Leukocyte; Ci

1996